treatment: Mesenchymal with OVOL1 overexpression:3
cell type: androgen-independent prostate cancer epithelial cells (PC-3):12
tissue: normal-looking surrounding colonic epithelium:18
transfection: lentivirus carrying BS69-1 shRNA:3
transfection: lentivirus carrying BS69-2 shRNA:3
genotype: C9orf72 Intron 1 Hexanucleotide Expansion:12
protein expressed: Flag-Stau1-WT (65KDa Isoform):9
cell type: hpSC derived Dopaminergic Neuron Precursors:3
differentiation stage: early basophilic erythroblasts:3
cell type: iPSC derived macrophage (IPSDM):6
diagnosis: Hepatosplenic T-cell lymphoma (HSTL):4
treatment: stored at room temperature:12
treated with: 100 nM 17ß-estradiol (E2) for 40min:3
tissue type: glioma - contrast-enhancing sample:39
treatment: infection with adenovirus with EGFR:6
treated with: si RNAs against control (scrambled):6
number of days in vitro in terminal differentiation conditions: 31:20
cell type: Undifferentiated nuclear-transfer embryonic stem cells:6
treated with: 0.5% dimethyl sulfoxide (DMSO) for 24hrs:6
developmental stage: 7 week gestation:66
developmental stage: 11 week gestation:55
treatment: infected with constitutively-active RelAS536E & treated with DMSO:3
cell stimulation: Phorbal myristate acetate (PMA) stimulation:24
history of brucellosis: Acute brucellosis:76
history of brucellosis: NA; healthy control:47
response to treatment of brucellosis: Complete remission:76
cell type: day 10 ES cells differentiating along the cardiac lineage:10
cell origin: made from CD34+ PBMC-derived induced pluripotent stem cells:6
treatment: 20nM Ctrl siRNA - Dharmacon:6
bacterial infection: M. abscessus Rough (MAB-R)-infected:9
tissue: nomral lung tissue adjacent to benign pulmonary tumors:5
Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy):789
Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement):260
Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement):127
HEAD AND NECK SQUAMOUS CELL CARCINOMA:536
LUNG ADENOCARCINOMA- NOT OTHERWISE SPECIFIED (NOS):386
LUNG SQUAMOUS CELL CARCINOMA- NOT OTHERWISE SPECIFIED (NOS):523
STOMACH  ADENOCARCINOMA  NOT OTHERWISE SPECIFIED (NOS):171
THYROID PAPILLARY CARCINOMA - CLASSICAL/USUAL:413
Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy):472

treatment + genetic modification + timepoint